Compound Zaofan Pill consolidation therapy of 40 cases of non-severe aplastic anemia.docVIP

 PAGE \* MERGEFORMAT 7 Compound Zaofan Pill consolidation therapy of 40 cases of non-severe aplastic anemia [Paper Keywords] Compound Zaofan Pill; consolidation therapy; non-severe aplastic anemia; continuous complete remission [Abstract] Objective: To observe the compound Zaofan Pill in the non-SAA in the efficacy of consolidation therapy. Methods: 40 cases of systemic therapy after complete remission of non-severe aplastic anemia patients were randomly divided into treatment group 20 cases, in order to compound Zaofan Pill as a consolidation therapy drugs; control group, 20 patients with androgen Andriol as a consolidation therapy to maintain therapeutic drug. Results: The treatment group continued to ease in 12 cases, occurred in 8 cases of blood, as repeated and sustained remission rate was 60%; the control group continued to ease in 13 cases, occurred in 7 cases of blood, as repeated and sustained remission rate was 65%. Conclusion: Compound Zaofan Pill consolidation of non-severe aplastic anemia treatment with effective drugs. Aplastic anemia (AA for short) is a physical, chemical, biological, or under the action of unknown factors, so that bone marrow hematopoietic stem cells and bone marrow micro-environment severely damaged, resulting in reduced bone marrow function or failure of the disease [1], clinical can be divided into severe aplastic anemia (SAA) and non-severe aplastic anemia (SAA), in which a non-severe aplastic anemia is more common. This part of the standard for the treatment of patients who were available to hematopoietic function recovery, clinical remission or basic accounting for about 70% cured, but the subsequent consolidation therapy is often more important. Use of conventional consolidation therapy androgen, have more side effects, liver damage and often affect women’s masculine treatment, caused by the disease again. The last 3 years, we have non-severe aplastic anemia using standard system remission, 20 patients, use of pure C